Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: a position paper of the MeetURO Group / Procopio, G; Pignata, S; Altavilla, A; Attademo, L; De Lisi, D; Verzoni, E; De Giorgi, U; Santini, D. - In: FUTURE ONCOLOGY. - ISSN 1479-6694. - 15:22(2019), pp. 2657-2666. [10.2217/fon-2018-0857]
Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: a position paper of the MeetURO Group
Santini D
2019
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


